CGC
CGC clinical trials: Canopy Growth Corp
Every trial on ClinicalTrials.gov where Canopy Growth Corp is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 13
- Trials linked
- 10
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CGC on the catalyst calendar · CGC registry changes
- Primary completion Dec 6, 2022ActualPhase 1/Phase 2NCT05839964A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep QualityCanopy Growth Corporation · Healthy AdultsCompletedCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 23, 2021ActualPhase 2NCT05679830The Effects of CBD Isolate on Menstrual-Related SymptomsCanopy Growth Corporation · Menstrual DiscomfortCompletedCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 22, 2022ActualPhase 1NCT05317013CBD in Postmenopausal Women With OsteopeniaCanopy Growth Corporation · OsteopeniaTerminatedCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 30, 2023Sponsor estimateNo phase registeredNCT04763252Canadian Registry for the Use of Spectrum Therapeutics Cannabis Products in Subjects With Chronic PainCanopy Growth Corporation · Chronic PainUnknown statusCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 6, 2022ActualPhase 1NCT05210634Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy ParticipantsCanopy Growth Corporation · Healthy AdultsCompletedCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 4, 2022ActualPhase 2NCT05026164Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical ActivityCanopy Growth Corporation · Delayed Onset Muscle Soreness (DOMS)CompletedCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 15, 2021ActualPhase 2NCT04577612A Randomized Controlled Test of the Effects of CHI-554 on Fear.Canopy Growth Corporation · AnxietyCompletedCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2021ActualPhase 2NCT04269252CHI-907 CBD Extract and Experiences of Test AnxietyCanopy Growth Corporation · AnxietyTerminatedCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 17, 2020ActualPhase 2NCT03984604Investigation of the Efficacy and Safety of CHI-921 in Insomnia.Canopy Growth Corporation · InsomniaTerminatedCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 26, 2021Sponsor estimatePhase 2NCT04086342CHI-902 for Treatment of Social Anxiety DisorderCanopy Growth Corporation · Social Anxiety DisorderWithdrawnCGCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 15, 2025ActualPhase 1NCT05324982Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy ParticipantsUniversity of Maryland, Baltimore · Behavioral Pharmacology of CannabisCompletedCGCCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2, 2024ActualEarly Phase 1NCT05478863The Pharmacodynamics of Cannabinoid-Caffeine CombinationsJohns Hopkins University · Behavioral Pharmacology of CannabinoidsCompletedCGCCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 17, 2024ActualPhase 1NCT04283019The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure ConditionsJohns Hopkins University · Cannabis, Drug EffectsCompletedCGCCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 13 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner